GIBCO TM products for hybridoma culture have been designed and optimized for the serum-free growth of a variety of hybridoma cell lines and production of monoclonal antibodies.
Traditional hybridoma culture media requiring serum supplementation have in recent years been replaced by a variety of commercially available serum-free formulations. Many serum-free formulations contain proteins (e.g., insulin, transferrin, albumin) and/or protein hydrolysates and lysates. As a result of a trend towards greater levels of media definition and the need for replacement of components of animal origin with non-animal derived materials, many serum free media formulations are considered unacceptable for certain applications. Hybridoma-SFM and PFHM II represent a spectrum of serum-free products for growth of hybridomas and monoclonal antibody production. Hybridoma-SFM is a serum-free, low protein (20 μg/mL protein as insulin and transferrin) medium that supports growth and monoclonal antibody production of a variety of hybridoma cell lines. PFHM II is a protein-free, chemically defined medium that is intended as a monoclonal antibody production medium, although it also has been used to grow a variety of hybridoma cell lines.
|Contains insulin and transferrin||X|
|Contains Phenol red||X||X|
|Contains inorganic iron|
* PFHM II does not contain a surfactant. If used for agitated suspension culture, supplement with 0.1% PLURONIC F-68
** Medium should be pre-screened to determine potential interference of inorganic iron carrier(s) with antibody detection and/or purification method.
Hybridoma-SFM and PFHM II work well for a variety of hybridoma systems, but will not grow cholesterol dependen cell lines (e.g., NS0 and derivatives) without further supplementation. Supplementation with a lipoprotein preparation or other source of cholesterol will be required for cholesterol dependent cell lines. Addition of antibiotics should not be used as a substitute for proper sterile technique. In most instances, antibiotics are neither necessary nor advised. However, in those instances where antibiotics are desired, most general antibiotics are compatible with PFHM II including penicillin/streptomycin, gentamicin, anti-PPLO, linocin and Fungizone. It is important not to use the following: kanamycin sulfates, neomycin sulfates or penicillin/streptomycin/neomycin mixtures
Instructions for Use
37° C + 0.5°C in a humidified atmosphere of 5 - 10% CO2 in air. Caps of flasks should be loosened to permit gas exchange. Cultures may be grown in stationary suspension culture (e.g., T-flask) or in agitated suspension culture (shaker or spinner flasks). Adequate headspace should be provided to facilitate gas exchange. (e.g., for a 125 mL shaker flask, use no more than 35 mL culture volume). Shaker flasks should be rotated at 125 - 135 rpm; agitation speed in spinner flasks will depend upon the impeller design. Protect cultures from light.
Adaptation of Cells to Serum-free or Protein-free Media
A sequential adaptation protocol may be necessary if direct adaptation does not work. In both cases, the cells should be in mid-logarithmic growth phase with high (>90%) viability. Success of the adaptation method will depend upon the particular hybridoma cell line and the culture conditions employed. It is recommended that backup cultures in the original medium be maintained until success with the new medium has been achieved.
A. Direct Adaptation
- Transfer hybridoma cells growing in serum supplemented medium to serum-free medium which has been prewarmed to 37° C. Seeding= density should be double the normal seeding density for the cell line. Incubate the cells at 37° C in a humidified atmosphere of 5-10% CO2 in air.
- Monitor cell growth until viable cell density reaches 1 x 106/mL. Subculture the cells to a viable cell density of 1- x 105/mL in fresh serum-free medium. Subculture in this manner, monitoring cell growth and viability, for 3 to 5 passages.
- If the culture fails to maintain acceptable growth and viability over 3-5 passages during direct adaptation, use the sequential adaptation method.
B. Sequential Adaptation
- Inoculate hybridoma cells at double the normal seeding density in a 75:25 (v/v) mixture of serum supplemented : serum-free medium.
- Monitor the culture until the density reaches 1 x 106 viable cells/mL. Then subculture into a 50:50 (v/v) mixture of serum supplemented : serum-free medium.
- Monitor the culture until the density reaches 1 x 106 viable cells/mL. Then subculture into a 25:75 (v/v) mixture of serum supplemented : serum-free medium.
- Monitor the culture until the density reaches 1 x 106 viable cells/mL. Then subculture into 100% serum-free medium.
- NOTE that it may be necessary to subculture more than once into a given mixture of serum supplemented : serum-free medium until the cells become acclimated. It is advisable to keep a backup culture in the previous media mixture until the cells have adapted.
- Prepare desired quantity of cells, harvesting in mid-log phase of growth with viability > 90%.
- Determine the viable cell density and calculate the required volume of cryopreservation medium (50% fresh medium : 50% conditioned medium1 + DMSO to a final concentration of 7.5%) to give a final cell density of 0.5 - 1.0 x 107 cells/mL.
- Prepare the required volume of cryopreservation medium and hold the medium at 4° C until use (make cryopreservation medium on day of intended use).
- Pellet the cells from culture medium at 100 x g for 5 minutes. Resuspend the pellet in the pre-determined volume of 4° C cryopreservation medium.
- Dispense aliquots of this suspension into cryovials according to the manufacturer’s specifications (e.g., 4.5 mL in a 5.0 mL vial).
- Achieve cryopreservation in either an automated or manual controlled rate freezing apparatus following standard procedures (1° C decrease per minute).
- Frozen cells are stable indefinitely under liquid nitrogen.
1 Note that conditioned medium should be obtained from a high viability, midlog culture of cells.
Recovery from Cryopreservation
- Recover cultures from frozen storage by rapid thawing of a vial of cells in a 37° C water bath with shaking just until the medium thaws.
- Transfer the entire contents of the vial into the appropriately sized vessel so that the cells are seeded at 5 x 105 cells/mL of complete growth medium.
- Incubate the culture in a humidified atmosphere of 5-10% CO2 in air at 37+0.5° C. Do not centrifuge the cells a they are extremely fragile upon recovery from cryopreservation.
- Maintain the culture between 5 x 105 and 10 x 105 viable cells/mL for the first two subcultures following recovery; thereafter, returning to the normal maintenance schedule.
GIBCO specialty media for hybridoma applications are performance tested using either a myeloma or hybridoma cell line. Additional standard evaluations are pH, osmolality and tests for the absence of bacterial and fungal contaminants.